Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies
Jinqiu Yuan, Qiangsheng He, Long H. Nguyen, et al.
Gut (2020) Vol. 70, Iss. 6, pp. 1070-1077
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
Ali Nabavi-Rad, Amir Sadeghi, Hamid Asadzadeh Aghdaei, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 73
Current state of research on the clinical benefits of herbal medicines for non-life-threatening ailments
Sandra Salm, Jochen Rutz, Marjan van den Akker, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Association between antibiotics use and diabetes incidence in a nationally representative retrospective cohort among Koreans
Sun Jae Park, Young Jun Park, Jooyoung Chang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China
Yanbo Zhang, Xiong‐Fei Pan, Qi Lu, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 2044-2055
Open Access | Times Cited: 27
Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study
Stefano Ciardullo, Federico Rea, Laura Savaré, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. e2671-e2679
Open Access | Times Cited: 24
Association and Mechanisms of Proton Pump Inhibitors Use with Type-2 Diabetes Mellitus Incidence in Adults: A Systemic Review and Meta-Analysis
Santenna Chenchula, Phulen Sharma, Mohan Krishna Ghanta, et al.
Current Diabetes Reviews (2024) Vol. 20, Iss. 10
Closed Access | Times Cited: 4
Impact of anti-peptic ulcer disease medications on type 2 diabetes mellitus risk in patients with PUD: a population-based retrospective cohort study
Yi‐Jen Fang, Hui-Hsia Hsieh, Cheng‐Li Lin, et al.
Therapeutic Advances in Endocrinology and Metabolism (2025) Vol. 16
Open Access
The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System
Ali Nabavi-Rad, Mahsa Azizi, Shaghayegh Jamshidizadeh, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 18
Regular proton pump inhibitor use and incident dementia: population-based cohort study
Peidong Zhang, Zhihao Li, Peiliang Chen, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease
Tenzin Choden, Zhang Hui, Atsushi Sakuraba
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 10
Proton pump inhibitors are associated with incident type 2 diabetes mellitus in a prospective population‐based cohort study
Petra Czarniak, Fariba Ahmadizar, Jeff Hughes, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 6, pp. 2718-2726
Open Access | Times Cited: 22
Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-analysis
Carol Chiung‐Hui Peng, Yu‐Kang Tu, Gin Yi Lee, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 11, pp. 3354-3366
Open Access | Times Cited: 19
Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials
Man Yang, Qiangsheng He, Fang Gao, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 18
Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study
Zhihao Li, Wen-Fang Zhong, Cheng-Shen Qiu, et al.
International Journal of Cardiology (2023) Vol. 395, pp. 131567-131567
Closed Access | Times Cited: 7
Association between the Use of Proton Pump Inhibitors and Cardiovascular Diseases: A Nested Case‒Control Study Using a National Health Screening Cohort
Sarang Jang, Hyo Geun Choi, Mi Jung Kwon, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 170-170
Open Access | Times Cited: 2
Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank
Xing-Yu Zhang, Qiangsheng He, Zhong Jing, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants
Man Yang, Bin Xia, Ya‐Wen Lu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 10
Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes
Tingting Geng, Jun‐Xiang Chen, Yanfeng Zhou, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. e216-e222
Closed Access | Times Cited: 9
Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
Niels Westergaard, Lise Tarnow, Charlotte Vermehren
Metabolites (2021) Vol. 11, Iss. 2, pp. 96-96
Open Access | Times Cited: 12
Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case–Control Study
Hsin-Ya Kuo, Chih‐Sung Liang, Shih‐Jen Tsai, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8739-8739
Open Access | Times Cited: 8
Proton Pump Inhibitors in Germany: Status Quo of a Growing Market
Kate Plehhova, Monika Häring, Joshua Wray, et al.
Health Services Research and Managerial Epidemiology (2024) Vol. 11
Open Access | Times Cited: 1
Ideal cardiovascular health and mortality: pooled results of three prospective cohorts in Chinese adults
Yanbo Zhang, Canqing Yu, Shuohua Chen, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 4
Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
Yun-Ran Guo, Xinming Liu, Guixia Wang
World Journal of Diabetes (2023) Vol. 14, Iss. 2, pp. 120-129
Open Access | Times Cited: 4
Twenty-three medication-taking traits and stroke: A comprehensive Mendelian randomization study
Wenbo Shao, Taozhi Li, Yukun Wang, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Alterations in gut microbiota and bile acids by proton‐pump inhibitor use and possible mediating effects on elevated glucose levels and insulin resistance
Qiangsheng He, Bin Xia, Man Sik Yang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top